Owen Kim is an associate in the Mergers & Acquisitions Practice Group, and is resident in the New York office. Mr. Kim focuses his practice on the representation of corporate clients and private equity funds in connection with domestic and global mergers, acquisitions and equity investments.
Representative matters include the representation of:
Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, in the US$500 million acquisition of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX).
Baxter International Inc. (NYSE: BAX), in its US$350 million acquisition of the Seprafilm adhesion barrier device and related assets from Sanofi S.A. (NASDAQ: SNY).
Advanz Pharma, the global pharmaceuticals group, in its acquisition of Correvio Pharma.
Clariant Corporation, Clariant Produkte (Deutschland) GmbH, SCG Chemicals (Singapore) Pte., Ltd. and Hexagon International, Inc., 50% equityholders of GTC Technology US, LLC and GTC Technology International LP, a global licensor of process technologies, process equipment solutions, chemicals and catalysts to the petrochemical, refinery and gas processing materials, in the sale of those entities to Sulzer US Holding Inc. and Sulzer AG.
Anthem, Inc. in the acquisition of Beacon Health Options, the largest independently held behavioral health organization in the country.
Investindustrial VI L.P. in the acquisition of Jupiter Holding I Corp., a global manufacturer of a global manufacturer of premium spas, swim spas, whirlpool, soaker and walk-in bathtubs and related bathroom products and accessories, operating under such brands as Jacuzzi®, Sundance®, Dimension One Spas®, Hydropool®, ThermoSpas® and BathWraps®.